All Stories

  1. Level of clinical evidence of herbal complementary therapies in psychiatric disorders

    Article • Psychiatry and Clinical Psychopharmacology, June 2019, Taylor & Francis

    Mesut Cetin, FEYZA ARICIOGLU

  2. Psychiatric pharmacogenomics in the age of neuroscience: promises and challenges

    Article • Psychiatry and Clinical Psychopharmacology, July 2018, Taylor & Francis

    Mesut Cetin

  3. Serious dermatological adverse effects of vortioxetine: two cases

    Article • Psychiatry and Clinical Psychopharmacology, June 2018, Taylor & Francis

    Mesut Cetin

  4. Cannabis-associated psychotic symptoms and neurocognitive effects at high risk psychosis patients

    Article • Psychiatry and Clinical Psychopharmacology, December 2017, Taylor & Francis

    Mesut Cetin

  5. Brexanolone: an allosteric modulator of GABA-A receptors in the rapid treatment of postpartum depression

    Article • Psychiatry and Clinical Psychopharmacology, September 2017, Taylor & Francis

    Mesut Cetin

  6. Ketamine and rapastinel: NMDA receptor modulators in the rapid treatment of obsessive-compulsive disorder

    Article • Psychiatry and Clinical Psychopharmacology, July 2017, Taylor & Francis

    Mesut Cetin

  7. Adverse drug reactions and causality: the Turkish version of Naranjo Adverse Drug Reactions Probability Scale

    Article • Psychiatry and Clinical Psychopharmacology, April 2017, Taylor & Francis

    Mesut Cetin

  8. Ketamine and electroconvulsive therapy pairing in depression and mood disorders

    Article • Psychiatry and Clinical Psychopharmacology, April 2017, Taylor & Francis

    Mesut Cetin